4//SEC Filing
Fairman Jeff 4
Accession 0001209191-22-016524
CIK 0001649094other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:56 PM ET
Size
8.8 KB
Accession
0001209191-22-016524
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Award
Common Stock
2022-03-02+6,000→ 16,629 total - Award
Stock Option (right to buy)
2022-03-02+33,000→ 33,000 totalExercise: $24.79Exp: 2032-03-01→ Common Stock (33,000 underlying)
Holdings
- 341,227(indirect: By Trust)
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
- [F2]1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813800
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:56 PM ET
- Size
- 8.8 KB